By Peter A. McCullough, MD, MPH
Anthony M Kyriakopoulos, Greg Nigh, Peter A McCullough, et al. Oncogenesis and autoimmunity as a result of mRNA COVID-19 vaccination. Authorea. April 23, 2024. DOI: 10.22541/au.171387387.73158754/v1
Skipping preclinical oncogenicity studies turned out to be a disaster for mRNA products. Concerns raised in this paper apply to any new mRNA product coding for a non-human or pathological protein target. Sadly, Moderna among many mRNA companies has plans for mRNA cancer drugs. They have a long drug development pathway to prove mRNA will not cause more cancer than it intends to treat.
Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
www.mcculloughfnd.org
Anthony M Kyriakopoulos, Greg Nigh, Peter A McCullough, et al. Oncogenesis and autoimmunity as a result of mRNA COVID-19 vaccination. Authorea. April 23, 2024. DOI: 10.22541/au.171387387.73158754/v1
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.